Dissociative Disorders Treatment: Psychotherapy, Evidence, and Safety
Author: Angela Bogdanova · Published: October 9, 2026 · Editorial Policy
Research cluster: Dissociation & Dissociative Disorders · Written by Artificial Sapiens
Treatment for dissociative disorders begins with a careful understanding of the symptoms, their impact on daily life, potential medical and psychiatric explanations, and the person's priorities and safety. Psychotherapy is central to care for many people with a diagnosed dissociative disorder. Treatment may focus on reducing disconnection, strengthening emotional and behavioral regulation, improving continuity of memory and daily functioning, addressing co-occurring conditions, and working with traumatic experiences when that is clinically relevant and tolerable. The appropriate plan differs substantially between depersonalization-derealization disorder, dissociative amnesia, dissociative identity disorder (DID), and other specified dissociative disorder (OSDD). For a related clinical perspective, see Dissociative Disorders: Types, Symptoms, Diagnosis, and Treatment.
The most important evidence distinction is between what clinicians commonly recommend and what controlled studies have demonstrated. An influential international specialist guideline describes phase-oriented care for adults with DID; it is expert-informed guidance issued in 2011. A 2025 systematic review of 19 studies found improvement with several psychological approaches for DID and OSDD but called for adequately powered controlled trials. A separate 2024 systematic review of depersonalization-derealization treatment found a small and heterogeneous evidence base. A treatment can therefore be clinically reasonable without having the same degree of trial support as therapies established for other diagnoses.
This article explains how clinicians choose and adapt treatment, what the research supports, how risks should be monitored, what medication can and cannot do, and what a person can expect from care. It addresses dissociative-disorder treatment as a whole. Specific DID protocols, grounding exercises, medication questions, and treatment during therapy have separate editorial homes in the English Psychology Hub.
What treatment is intended to accomplish
Successful treatment is measured by changes that matter to the individual: fewer disruptive dissociative episodes; better awareness of time, place, self and surroundings; improved ability to tolerate emotions; reduced unsafe behavior; more dependable memory and daily routines; healthier relationships; and participation in work, education, family and community life. Symptom reduction is important, but quality of life and functioning are equally meaningful outcomes.
For some people, the immediate need is an explanation of frightening episodes of unreality and a plan for managing them. Others have complex memory discontinuities, identity-state experiences, self-harm risk, sleep disruption or severe co-occurring symptoms. Some have a trauma history that requires attention; others do not identify a clear precipitating trauma. No single presumed cause should be imposed on every case.
Dissociation ranges from relatively common transient experiences to persistent clinical conditions. Brief detachment, absorption or zoning out does not by itself establish a disorder. Diagnosis requires evaluation of the pattern, duration, distress, impairment, cultural context and alternative explanations. The American Psychiatric Association's clinical overview and WHO ICD-11 clinical guidance provide two complementary diagnostic reference points.
First step: a thorough clinical assessment
A clinician typically begins by asking what the person experiences, when it occurs, how long it lasts, what changes it, and how it affects safety and functioning. Assessment may consider detachment from body or surroundings; dissociative amnesia; altered sense of agency or identity; episodes of confusion or lost time; sleep; substance and medication effects; exposure to stress; panic; depression; suicidality; and the person's cultural understanding of the experience.
The assessment should distinguish symptoms from a formal diagnosis. A screening questionnaire can identify experiences worth discussing, but a high score cannot independently confirm DID, OSDD or any other disorder. Structured diagnostic interviews, careful longitudinal history and collateral information used with consent can be helpful when presentation is complex. Assessment remains an evolving clinical process when neurological symptoms, sleep problems, intoxication, medication effects or severe mood changes are possible.
A medical or neurological workup is indicated when the history or examination suggests seizures, head injury, cognitive change, fainting, intoxication or another medical explanation. New-onset confusion, unexplained loss of consciousness, severe headache, focal weakness, or an acute deterioration may need urgent assessment rather than a psychotherapy appointment. The Merck Manual's professional discussion of dissociative amnesia describes the importance of excluding neurological and substance-related explanations for memory loss.
Does treatment change by dissociative diagnosis?
Depersonalization-derealization disorder
Depersonalization involves feeling detached from oneself, one's thoughts, body or actions. Derealization involves feeling that surroundings are unreal, distant or unfamiliar. In depersonalization-derealization disorder, these experiences recur or persist and cause clinically meaningful distress or impairment, while reality testing is generally preserved. Feeling as though the world is unreal does not mean believing that the world literally has ceased to exist.
Treatment commonly targets the feedback loop among anxiety, threat monitoring, repeated checking of one's own mental state and avoidance. Psychological approaches may include cognitive strategies, behavioral re-engagement, attention shifts and emotional awareness; co-occurring panic, depression or anxiety are treated according to their own needs. The Merck professional clinical overview describes these options, while the Wang et al. systematic review makes clear that reliable comparative treatment evidence remains limited. Supportive techniques can help individuals, but universal success rates cannot be inferred.
Dissociative amnesia
Dissociative amnesia concerns an inability to recall important autobiographical information that is inconsistent with ordinary forgetting and not better explained by substances, neurological illness or another condition. Treatment may begin with psychological safety, practical support, stabilization and assessment of impairment. For some patients, memory returns gradually; others require longer follow-up or assistance with continuing difficulties. Functional recovery can proceed even when not every memory gap is filled.
A crucial safeguard is to avoid treating therapy as a historical investigation with a predetermined answer. Hypnosis or medication-assisted interviews are described in some clinical literature, but they introduce important concerns about suggestibility, distress and uncertain accuracy. The Merck professional manual emphasizes caution and external corroboration when evaluating purportedly recovered memories. A person's suffering deserves care whether an autobiographical account can be independently verified or not.
Dissociative identity disorder
DID involves a clinically significant disruption of identity with discontinuities in sense of self or agency and recurrent gaps in recall, along with distress or impairment and exclusion of better explanations. The treatment literature concentrates on sustained psychotherapy, regulation skills, safety, cooperation across identity experiences, functioning and processing of relevant traumatic material when clinically indicated. Treatment is tailored rather than defined by the appearance of particular identity states in an interview.
Specialist guidance describes integration in the broad sense of increased coordination and continuity; some individuals and clinicians pursue a more unified sense of identity while others focus on stable cooperation and reduced impairment. The individual's goals, functioning and safety are central. A 2025 review of developments in DID care describes emerging alternatives and emphasizes the need for comparative trials. This general article does not substitute for the separate DID-specific treatment review planned under EN05-025.
Other specified dissociative disorder and other presentations
OSDD is used in DSM-5-TR when clinically significant dissociative symptoms do not meet the complete criteria for another specified dissociative disorder and the clinician records the reason. The appropriate formulation depends on the actual presentation, not an assumed hierarchy in which one label is automatically milder or more severe. ICD-11 also recognizes partial DID and other dissociative categories that do not map perfectly onto every DSM-5-TR label. Clinicians should use the classification relevant to their setting without pretending that two systems are identical.
Treatment may share selected elements with care for DID or other conditions, but results from a study of one diagnostic group should not automatically be generalized to all groups. The WHO diagnostic descriptions are the appropriate reference for the ICD-11 categories.
Psychotherapy: what happens in treatment?
An effective therapeutic relationship supports collaboration about goals, pace, safety and outcome monitoring. Early sessions often involve psychoeducation, developing an individualized explanation of symptoms, agreeing on a response plan for episodes, discussing sleep and daily structure, and identifying triggers or maintaining factors without presuming that every symptom has a single hidden meaning.
Therapy may later examine recurrent patterns of avoidance, fear, emotional overload, memory disruption, interpersonal stress and traumatic experiences when relevant. Progress is sometimes gradual, with improvements in practical functioning appearing before a change in dissociative symptoms. Periodic review is essential: if a strategy increases impairment, disorientation or risk, the plan should be adjusted rather than treated as a test of willingness to improve.
Phase-oriented treatment
Phase-oriented models, particularly associated with complex dissociative presentations, often describe three overlapping tasks. The first is safety, stabilization, psychoeducation and development of regulation skills. The second addresses traumatic experiences or other emotionally intense material when clinical conditions and consent support that work. The third emphasizes integration of experience, sustained functioning, relationships and future planning. These are flexible areas of work rather than a mandatory sequence with a fixed duration.
The ISSTD adult DID guideline describes this model as specialist consensus and informed practice. Its date matters: issued in 2011, it cannot be presented as proof that every element has passed modern randomized comparisons. The Griffiths et al. 2025 systematic review found improvements across phase-oriented and other psychotherapeutic approaches but insufficient robust comparative evidence to designate a universally superior model.
Clinical pacing is individualized. Some people need extended attention to day-to-day safety; others are ready for focused work on current symptoms or traumatic memories sooner. Endless stabilization without reassessing benefit can also have costs. Shared goals and regular measurement help prevent treatment from becoming directionless.
Cognitive and behavioral approaches
Cognitive behavioral approaches can target catastrophic interpretations of dissociative experiences, repetitive self-checking, avoidance and behaviors that narrow everyday life. Behavioral experiments, activity scheduling and attention training may be especially relevant to depersonalization-derealization symptoms. Adaptations for complex dissociation may include shorter exercises, enhanced orientation, careful monitoring of emotional arousal and a collaborative plan for memory discontinuities.
The broader success of CBT in anxiety or PTSD is insufficient evidence that the same protocol will treat every dissociative disorder. Diagnosis-specific controlled data remain comparatively scarce, as indicated by the DPDR systematic review and the 2025 DID/OSDD treatment synthesis. Clinicians must distinguish transdiagnostic skills from disorder-specific effectiveness claims.
Dialectical behavior therapy skills and emotional regulation
DBT-informed skills may help with emotion labeling, distress tolerance, interpersonal effectiveness, crisis planning and urges toward self-injury. These can be clinically useful targets when emotional dysregulation accompanies dissociation. However, trials of DBT in borderline personality disorder cannot be recast as direct proof that standard DBT treats DID or OSDD. The skills may be an appropriate component of a broader individualized plan, with outcomes monitored separately.
Psychodynamic, relational and integrative psychotherapy
Some clinicians use psychodynamic and relational approaches to explore emotional conflict, attachment experiences, defense, shame and recurring relationship patterns, while maintaining concrete safety and functioning goals. A systematic review of psychodynamically informed DID psychotherapy found reports of clinical improvement but a literature dominated by observational longitudinal reports, case series and case studies. Such designs are informative about feasibility and experience; they cannot reliably isolate treatment effects from spontaneous change, concurrent care or selection.
The therapeutic relationship itself may need particular attention when identity discontinuity, difficulties with trust or prior harmful experiences complicate collaboration. Transparency about limits, documentation and the possibility of discussing disagreements can be protective.
Trauma-focused therapies, EMDR and exposure
When trauma-related symptoms are part of an individual's formulation, a clinician may consider trauma-focused cognitive therapies, carefully adapted exposure or eye movement desensitization and reprocessing (EMDR). The key questions are which diagnosis is being treated, what intervention has direct supporting evidence in that population, and whether the person remains sufficiently oriented and safe during sessions.
There is strong treatment literature for PTSD, but that evidence is owned by the PTSD field and cannot automatically establish effectiveness for DID, dissociative amnesia or DPDR. Likewise, an individual's dissociation during exposure may require pacing changes, grounding and renewed assessment. The US Department of Veterans Affairs National Center for PTSD discusses special treatment concerns for the dissociative subtype of PTSD, a distinct diagnostic context.
Trauma processing should proceed through informed consent and an individually reviewed risk-benefit plan. Immediate intensive exploration of memories is not an indispensable first step for everyone, and reluctance to engage in a particular memory-focused technique is not evidence of denial or a hidden disorder.
Psychoeducation and structured skills programs
Psychoeducation can explain how dissociative symptoms may interact with arousal, stress, sleep, attention and learned responses; it can also help patients practice orientation and safety skills. Structured programs are increasingly being tested rather than accepted on plausibility alone.
The Finding Solid Ground randomized trial assigned 291 outpatients with different trauma-related dissociative presentations to immediate access or a six-month waitlist for an online psychoeducational adjunct while participants continued usual psychotherapy. The immediate-access group reported greater improvements at six months on emotion regulation, PTSD symptoms, self-compassion and adaptive functioning. The trial is valuable because it tested an additional intervention in a clinically complex population. It does not show that the program is sufficient as a stand-alone treatment, that results apply equally to each diagnosis, or that all long-term effects are established.
A 2026 naturalistic group study followed 72 adults recruited to a 31-week psychoeducation program; 47 completed all assessments. Reported improvements in dissociation, PTSD symptoms and functioning are encouraging, but the absence of random assignment and the sample characteristics restrict causal and generalizable conclusions. Both studies support further rigorous testing of skills-based adjuncts.
Grounding and present-moment orientation
Grounding is a family of strategies that directs attention to present surroundings and observable sensory information. Clinicians may help a person identify the date and place, orient toward objects in the room, feel the contact of the floor, describe a safe and familiar object, or arrange a predictable activity after a difficult session. Different people respond differently: intense sensory input, closing the eyes or body-focused exercises can be uncomfortable or destabilizing for some.
Grounding should be approached as a customizable coping aid and assessed for its actual benefit. It is not a diagnostic test or a stand-alone cure. The separate EN05-037 article will own detailed step-by-step techniques and their evidence limitations; PTSD-specific grounding remains under the PTSD canonical owner.
What does the scientific evidence actually show?
Evidence hierarchy for dissociative-disorder treatment
The most defensible summary is that clinical experience and observational research favor psychological treatment for many impairing dissociative presentations, while large, high-quality randomized comparisons remain limited. For DID and OSDD, the 19-study systematic review compared phase-oriented and other treatments and reported symptom improvement across approaches. Heterogeneous interventions, outcome measures, study designs and patient groups prevent a simple claim that one model is the best.
For DID, the 2025 review by Bachrach and Huntjens notes that historical phase-based psychotherapy research yielded modest effects on dissociative symptoms and that newer adapted approaches are promising but require replication. A promising innovation should be evaluated for durability, comparative benefit, adverse outcomes and affordability before it becomes a universal recommendation.
For DPDR, Wang et al. screened a broad body of literature but included only 41 reports involving 300 people; just four were randomized controlled trials. The review examined psychological, pharmacological and neuromodulation options with generally low-quality evidence. This is an argument for individualized care and better trials, not a claim that treatment is futile.
A Cochrane evidence review covering historically combined conversion and dissociative-disorder categories concluded that evidence for psychosocial interventions was low or very low in quality. Its diagnostic mixture means it cannot be used as a head-to-head estimate of modern DID or DPDR psychotherapy effectiveness. Distinguishing categories is essential when comparing reviews with different inclusion rules.
How to interpret outcome studies
Uncontrolled before-and-after improvement is compatible with benefit but cannot establish that therapy alone caused it. People may change with time, improved living conditions, medication changes, concurrent services or regression to the mean. Studies with high dropout may disproportionately represent those who tolerated treatment. A scale that records reduced dissociation may miss functioning, adverse events or differences in self-report response.
A well-designed study specifies the diagnosis and inclusion criteria, sample size, comparator, validated outcome measures, adverse-event collection, treatment fidelity and follow-up duration. It should also report how many patients deteriorated, rather than only how much the average score improved. Treatments for dissociative disorders need more of this kind of evidence.
Can psychotherapy make symptoms worse?
Any treatment can have burdens and risks. Temporary distress may occur when difficult emotions are discussed, but persistent disorientation, escalating self-harm, severe sleep disruption, unwanted dependency or a sustained deterioration in functioning call for clinical review. A systematic review of adverse-event reporting across psychotherapy trials found inconsistent methods and incomplete reporting. It was not a dissociative-disorder-specific trial, so its quantitative estimates should not be imposed on this population.
Patients benefit when clinicians ask directly about negative effects, invite disagreement and discuss alternatives. Consent, transparent goals and independent options for raising concerns are part of sound treatment rather than optional extras.
Treatment safety: memory, suggestion and the therapeutic relationship
Avoid leading memory-recovery methods
Clinicians should avoid leading questions, repeated pressure to produce forgotten material, and interpretations that treat a symptom as proof of an unremembered event. Human memory is reconstructive and susceptible to suggestion under some conditions. Hypnosis, guided imagery and emotionally intense interviews may be experienced as meaningful but do not convert a recalled image or narrative into independent evidence of historical accuracy.
Where memories emerge spontaneously or during care, a careful clinician responds to the emotional significance without guaranteeing literal accuracy. If historical verification matters for legal or safeguarding decisions, independent corroboration is a separate question. The Merck professional manual on dissociative amnesia explicitly warns about suggestion and the limits of memory accuracy following retrieval procedures.
A disagreement about the explanatory model of DID does not justify dismissing reported symptoms, and symptom reports do not adjudicate all causal models. Diagnosis and care focus on observable impairment, longitudinal history and a balanced clinical assessment.
Use an individualized safety plan
When episodes involve loss of awareness, unintentional injury risk, suicidality, self-harm, substance intoxication or unsafe travel, a safety plan may identify early signs, preferred grounding responses, trusted contacts, clinical access and emergency steps. Practical adaptations may include avoiding driving during episodes involving impaired awareness, arranging medication reminders or using calendars and written summaries to support continuity.
The plan should be reviewed as circumstances change. Severe suicidal intent, an active overdose, acute confusion or a medical emergency requires immediate local emergency care. In the United States, 988 is available for suicide and crisis support; people elsewhere should use local crisis services. Crisis pathways are not a substitute for ongoing diagnostic and therapeutic work.
Recognize concerning therapy practices
Warning signs include guaranteed claims to uncover hidden memories, insistence that a diagnosis can be established from an online checklist, pressure to accept a therapist's preferred identity narrative, secrecy that isolates the person from trusted support, retaliatory responses to questions, or refusal to reconsider treatment when functioning worsens. A treatment may be highly specialized and still require ordinary safeguards: informed consent, licensure and scope of practice, appropriate records, clear fees, boundaries, measurable goals and access to second opinions.
A healthy treatment relationship can accommodate uncertainty about causation and a patient's changing goals.
Medication: what role does it play?
No medication has been established as a general cure for dissociation or as a specific treatment that reverses DID. Medications may be used to treat co-occurring depression, anxiety, sleep difficulties, PTSD symptoms or another diagnosed psychiatric condition where benefit and risk justify them. Medication effects, including sedation, emotional blunting or cognitive changes, may themselves need review when dissociative symptoms are present.
The American Psychiatric Association explains that medications may help related conditions rather than directly treating DID. For DPDR, Wang et al. found insufficient high-quality evidence to recommend a reliably effective medication regimen across patients. Off-label medications should be discussed in terms of the exact target symptom, clinical alternatives, monitoring and uncertainty.
Medication decisions are made with a licensed prescriber. People should not change or discontinue prescribed medication based on an educational article.
Co-occurring conditions and differential diagnosis
Dissociative symptoms can coexist with anxiety, depression, PTSD, substance-use problems, sleep disorders and other psychiatric or medical conditions. The presence of one does not prove the cause of another. If a person has panic episodes with derealization, the initial treatment plan may need to target panic. If a person also meets criteria for PTSD, evidence-based PTSD treatment is considered according to that diagnosis. If a patient experiences a seizure-like event, neurological and functional-neurological evaluation may be necessary.
Clinicians distinguish depersonalization with preserved reality testing from psychotic symptoms involving fixed delusional interpretations; they distinguish amnesia from ordinary forgetfulness, attentional lapses or intoxication; and they assess identity disturbance in relation to development, culture, personality patterns and neurological explanations. ADHD-related inattention, BPD-related identity disturbance and functional seizures each have their own diagnostic pathways.
The WHO ICD-11 clinical manual reinforces diagnosis in its clinical and cultural context. Proper differential workup avoids both excessive labeling and missed medical problems.
How long does treatment take, and what is prognosis?
There is no trustworthy universal number of therapy sessions or guaranteed recovery timeline for all dissociative disorders. Some people experience marked relief when triggers, sleep disturbance or co-occurring anxiety are addressed. Others need sustained treatment for complex symptoms, recurrent risk, coexisting conditions or longstanding social and functional problems.
Length of care can depend on diagnosis, severity, safety, therapeutic alliance, access, treatment fit and practical pressures such as cost and transportation. People can improve without remembering every missing event or achieving a particular theory-based definition of identity integration. Follow-up may include relapse planning, renewed symptom assessment, medication review when relevant, and continued attention to school, employment and relationships.
Researchers still need stronger longitudinal outcome data on comparative treatments, dropout, relapse, meaningful recovery and adverse effects. A reader should distrust precise success percentages that do not identify a specific studied population and outcome.
Choosing a qualified therapist
A useful first question is whether the clinician is licensed in the relevant jurisdiction and has training appropriate to the presenting symptoms. Experience with dissociation may matter for complex identity discontinuity or memory complaints; experience with panic, DPDR or co-occurring depression may be equally relevant depending on the assessment. The most appropriate specialist may collaborate with primary care, psychiatry or neurology.
Ask how the clinician assesses dissociative symptoms and medical differentials, what treatment goals will be tracked, which methods are proposed, what the supporting evidence is for the particular diagnosis, and how the plan changes if symptoms worsen. Ask about handling uncertainty around memory, coordination with other providers, emergency procedures and options if the approach is ineffective.
Insurance coverage, telehealth rules, disability accommodations and session costs may shape what care is possible. A realistic plan respects these constraints and helps the individual identify attainable short-term goals.
Practical steps while arranging care
Keeping brief, factual notes about when symptoms occur, associated sleep loss, medication changes, stressors and practical consequences may help a clinician identify patterns. A symptom diary is a record of experience, not a way to prove a particular diagnosis or discover a hidden cause. Written schedules, reminders and simple orientation routines can reduce day-to-day disruption for some people.
Regular sleep, food, hydration, social contact and medically appropriate physical activity are supportive measures. They do not replace clinical care for an impairing disorder. People who experience episodes affecting awareness should discuss driving, operating equipment and other safety-sensitive activities with a clinician.
Friends and family can ask what support is preferred, speak calmly, avoid confrontational demands for an explanation, and assist with appointments and practical needs when invited. Their role is supportive rather than diagnostic.
Frequently asked questions
What is the best treatment for dissociative disorders?
Psychotherapy is often the main component of treatment, but the best approach depends on the assessed diagnosis, risks, comorbidities and patient preferences. Research currently does not establish one universally superior psychotherapy across DID, OSDD, DPDR and dissociative amnesia. The 2025 systematic review supports a measured assessment of emerging options.
Can dissociative disorders be cured?
Some people experience substantial symptom remission and durable functional improvement. The research does not provide a single cure rate for the whole diagnostic group. Recovery goals often include safety, continuity, participation and quality of life in addition to symptom scores.
Is trauma therapy necessary for every person who dissociates?
No. Dissociative experiences have different contexts, and not every person reporting them has a trauma-related disorder. Trauma-focused work may be appropriate when clinically supported and agreed to, with pacing adapted to safety and tolerability.
Is phase-oriented therapy proven to be the best approach?
It is widely described in specialist DID guidance and is a coherent clinical framework, but controlled comparative evidence is still developing. Observational improvements do not establish that the full phase sequence is superior for every patient.
Can CBT help depersonalization and derealization?
CBT-informed techniques may help some people with fear, repetitive checking and avoidance, but systematic evidence for DPDR treatment remains limited. Treatment selection should reflect the individual presentation and relevant comorbidity.
Are grounding techniques a treatment by themselves?
Grounding may help someone orient during an episode, and it can be incorporated into psychotherapy. It is best understood as an adaptable coping skill rather than an established stand-alone treatment that eliminates a disorder.
Is medication effective for dissociative identity disorder?
No medication has been established to directly resolve the core identity disruption of DID. Medication may address co-occurring conditions or target symptoms after evaluation by a prescriber.
Should a therapist help recover hidden memories?
Treatment should prioritize present safety and functioning. Techniques designed to recover memories can create suggestibility and accuracy problems. Historical claims need independent evaluation; therapeutic distress and memory certainty are separate matters.
Can hypnosis help with dissociation?
Some clinicians use hypnosis within broader care, but response varies, and its use requires informed consent and safeguards against leading suggestions and unverified claims about memory. It is not required for diagnosis or successful care.
Does a dissociation questionnaire tell me which treatment I need?
No. A self-report scale can help organize information for a clinician. Treatment planning requires clinical assessment, functional context and, when indicated, medical differential diagnosis.
Can treatment cause more dissociation?
Symptoms may fluctuate, and some methods or pacing choices may increase distress or detachment. Sustained deterioration, new safety risks or concerning therapist behavior warrant prompt reassessment and possibly a second clinical opinion.
How can I help someone whose dissociation interferes with daily life?
Offer calm practical support, ask what is useful, respect their preferences and encourage qualified assessment. Assist with safety and urgent care when needed, without assigning a diagnosis or pressing for autobiographical explanations.
Related Articles
References
American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.; DSM-5-TR). American Psychiatric Association Publishing.
American Psychiatric Association. (n.d.). What are dissociative disorders? Psychiatry.org.
Bachrach, N., & Huntjens, R. J. C. (2025). Recent evidence-based developments in the treatment of DID. Frontiers in Psychiatry, 16, 1650164. DOI: 10.3389/fpsyt.2025.1650164.
Brand, B. L., Schielke, H. J., Putnam, K., et al. (2025). A randomized controlled trial assists individuals with complex trauma and dissociation in Finding Solid Ground. Psychological Trauma, 17(8), 1717–1727. DOI: 10.1037/tra0001871.
Cochrane. (2020). Therapeutic and social interventions for conversion and dissociative disorders. Cochrane Evidence.
Griffiths, T. A., Dimitrova, L. I., Linington, M., Terhune, D. B., & Reinders, A. A. T. S. (2025). Effectiveness of phase-oriented treatment for trauma-related dissociative disorders: A systematic review. European Journal of Psychotraumatology, 16(1), 2545734. DOI: 10.1080/20008066.2025.2545734.
Hawkins, L., Johnson, S., Chipps, S., et al. (2026). Group-based psychoeducation for dissociative disorders: Reducing PTSD and dissociative symptoms while enhancing emotion regulation and adaptive capacity. Psychological Trauma. Advance online publication. DOI: 10.1037/tra0002162.
International Society for the Study of Trauma and Dissociation. (2011). Guidelines for treating dissociative identity disorder in adults, third revision. Journal of Trauma & Dissociation, 12(2), 115–187. DOI: 10.1080/15299732.2011.537247.
Klatte, R., Strauss, B., Flückiger, C., & Rosendahl, J. (2025). Adverse events in psychotherapy randomized controlled trials: A systematic review. Psychotherapy Research, 35(1), 84–99. DOI: 10.1080/10503307.2023.2286992.
Merck Manual Professional Edition. (n.d.). Depersonalization/derealization disorder. Clinical reference.
Merck Manual Professional Edition. (2025). Dissociative amnesia. Clinical reference.
Merck Manual Professional Edition. (n.d.). Dissociative identity disorder. Clinical reference.
U.S. Department of Veterans Affairs, National Center for PTSD. (n.d.). Dissociative subtype of PTSD. PTSD: National Center for PTSD. Official clinical resource.
Wang, S., Zheng, S., Zhang, X., Ma, R., Feng, S., Song, M., Zhu, H., & Jia, H. (2024). The treatment of depersonalization-derealization disorder: A systematic review. Journal of Trauma & Dissociation, 25(1), 6–29. DOI: 10.1080/15299732.2023.2231920.
World Health Organization. (2024). Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders (CDDR). WHO.
Yeates, S., Korner, A., & McLean, L. (2024). A systematic review and narrative analysis of the evidence for individual psychodynamically informed psychotherapy in the treatment of dissociative identity disorder in adults. Journal of Trauma & Dissociation, 25(2), 248–278. DOI: 10.1080/15299732.2023.2293802.